diabetes tirzepatide Improved Weight, Control in Patients With HIV Tirzepatide for Obesity and Diabetes

Sometimes the patches spread slowly, sometimes fast

While standard therapeutic doses have demonstrated cardiovascular and metabolic benefits in large clinical trials, the concept of using low dose GLP-1 for inflammation remains investigational, with no established FDA indication or standardized dosing protocols

Yet, the California State Board of Pharmacy (BOP) is trying to restrict access to compounded glutathione and dozens of other treatments, endangering lives

Initially developed as a treatment for type 2 diabetes, the drug gained widespread attention after clinical trials showed it reduced baseline body weight by approximately 10%-15%